Alcresta, Inc.
Country not established
- Devices
- 1
What Alcresta, Inc. makes
Alcresta, Inc. manufactures RELIZORB, a medical device designed for the removal of excess fluid from the peritoneal cavity, primarily used in patients with refractory ascites.
RELIZORB is classified as a Class II device under FDA regulations and is authorised via the 510(k) pathway. The company is based in the United States.
Catalogue
Relizorb Ref DEN150001
Regimes: De Novo Registry: De Novo
Frequently asked questions
How many devices does Alcresta, Inc. have in the registry?
The registry currently lists 1 device for Alcresta, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Alcresta, Inc.'s devices?
Among its 1 most recently registered device, Alcresta, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Alcresta, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Alcresta, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Alcresta, Inc. in the registry?
The most recently registered devices listed for Alcresta, Inc. include RELIZORB.